NovoCure Ltd. (NVCR)
NASDAQ · Healthcare
NovoCure Ltd. Operating Income 2013–2025
NovoCure Ltd. annual/quarterly operating income history and growth rate from 2013 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- NovoCure Ltd. operating income for the quarter ending March 31, 2026 was -67.4 M, a 78.05% increase year-over-year.
- NovoCure Ltd. operating income for the twelve months ending March 31, 2026 was -180.8 M, a 9.30% increase year-over-year.
- NovoCure Ltd. annual operating income for 2025 was -153.8 M, a 9.79% decrease from 2024.
- NovoCure Ltd. annual operating income for 2024 was -170.5 M, a 26.78% decrease from 2023.
- NovoCure Ltd. annual operating income for 2023 was -232.9 M, a 160.12% increase from 2022.
- NovoCure Ltd. annual operating income for 2022 was -89.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NovoCure Ltd. Operating Income — FAQ
NovoCure Ltd. (NVCR) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is NovoCure Ltd.'s operating income?
NovoCure Ltd. (NVCR) reported operating income of -$154M for fiscal 2025.
Where can I see NVCR's operating income history?
The chart and table above show NovoCure Ltd.'s operating income by year and by quarter, including the growth rate.